Cargando…
Companion Diagnostics for Targeted Cancer Drugs – Clinical and Regulatory Aspects
Companion diagnostics (CDx) holds the promise of improving the predictability of the oncology drug development process and become an important tool for the oncologist in relation to the choice of treatment for the individual patient. A number of drug–diagnostic co-development programs have already b...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032883/ https://www.ncbi.nlm.nih.gov/pubmed/24904822 http://dx.doi.org/10.3389/fonc.2014.00105 |